Structure-Based Design and Computational Validation of Novel 1,3,4-Thiadiazole-Peptide Conjugates as Selective Cyclin-Dependent Kinase-2 (CDK2) Inhibitors for Lung Cancer Therapy. Pjmcr [Internet]. 2026 Apr. 30 [cited 2026 Apr. 30];5(2):1174-80. Available from: https://pakjmcr.com/index.php/1/article/view/903